The Effectiveness of Trauma Focused Art Therapy (TFAT)

March 13, 2024 updated by: Suzanne Haeyen, HAN University of Applied Sciences

The Effectiveness of Trauma Focused Art Therapy: a Multiple Baseline Single Case Experimental Design

More than 30% of patients with trauma-related complaints do not benefit from prescribed treatments. This concerns patients who have either a poor verbal memory or who are unable or do not wish to talk about their experiences.

In clinical practice, trauma-oriented art therapy appears to be an appropriate treatment. The visual, tangible, experiential character of art therapy is in line with the often wordless, visual and sensory nature of trauma.

Art therapy aims to contribute to achieving personal goals through the use of visual materials and techniques. This approach has been insufficiently examined. Treatment of refugees with Trauma-Focused Art Therapy has previously been shown to be feasible in clinical practice and acceptable to patients.

Using a Mixed Method design, the researchers aim to measure the effect of this protocol in specialized mental health care and the experience of patients with regard to their personal recovery.

Study Overview

Status

Recruiting

Detailed Description

INTRODUCTION:

About four in five people experience one or more distressing events in their lives. Ten percent of people subsequently develop post-traumatic stress disorder (PTSD). About 1.3 million people in the Netherlands will therefore have to deal with the consequences of PTSD at some point. PTSD is an anxiety disorder and causes serious complaints of re-experience, avoidance and increased irritability as a result of exposure to one or more traumatic events. The disorder causes significant distress or impairment in social, occupational, or other important areas of functioning,

According to the Anxiety Disorders Guideline and the guidelines of the National Institute for Health and Care Excellence (NICE), Cognitive Behavioral Therapy (CBT) and Eye Movement Desensitization and Reprocessing (EMDR) are the preferred treatments for PTSD. However, these interventions do not work for everyone - more than a third of patients do not benefit. This includes patients with very severe traumatization, with poor verbal memory and patients who are unable or patients who find it difficult to talk about the traumatic experiences.

Practice shows that art therapy (AT) offers an appropriate treatment for these patients. This is because the visual, tactile and experiential nature of AT fits well with the often wordless, visual and sensory nature of traumatic memories. Trauma-focused AT provides access to memories and emotions, can help to put these into words, and can be a possible preliminary stage (pretherapy) for other trauma-focused treatments (such as EMDR, CBT or NET).

Patient representatives underline the availability of trauma treatment based on AT because they believe that it offers an essential alternative to the usual verbal, often cognitive therapeutic approach. In addition, the Improvement Report Posttraumatic Stress Disorders from the Netherlands Healthcare Institute mentions, as one of the most important points for improvement, that more people with PTSD should receive specific trauma-oriented treatment.

AT is one of the arts therapies: The treatment tradition of arts therapies spans about a century and includes the disciplines: visual, drama, dance, music and psychomotor therapy. AT works through the use of numerous visual materials, methods and techniques to give meaning to past events and to gain more control over one's own life.

AT distinguishes itself from other treatments by its experiential approach and by the visible and tangible nature of the process and product of the treatment. Acting, doing and experiencing with visual material removes the feeling of powerlessness, increases the sense of control and the sense of self-worth. Working with visual material triggers emotions: it allows access to traumatic memories and emotions (AT makes it possible to express and shape, integrate and accommodate traumatic memories in a safe and staged way. The result of the visual work is visible, tangible and has a lasting character. This allows one to literally distance themselves from the emotion, integrate it cognitively and assign meaning. AT is more often applied in practice with good results according to patients and professionals, but has been insufficiently examined.

A Trauma-Focused Art Therapy protocol was previously developed. In a pilot study with patients with early childhood traumatization, this protocol was found to be acceptable, feasible and applicable. This protocol lends itself to transferring this method between art therapists, but has not yet been further investigated for effectiveness. In this project, this protocol is implemented, tested and evaluated by patients and professionals.

The Trauma-Focused Art Therapy protocol offers opportunities to improve accessibility, quality and effectiveness of trauma treatment, because patients who would otherwise not be treated or who would receive long-term treatments without results, now receive appropriate treatment. This concerns a short-term, individual trauma-focused AT consisting of 10 sessions (60 min.) in three phases (I: Stabilization and symptom reduction; II: Trauma processing; III: integration and attribution of meaning). After the first phase of getting acquainted, creating safety and determining a list of memories, phase 2 works on expressing and shaping positive and negative feelings, memories and thoughts. Phase 3 focuses on reordering, merging and finalizing the AT.

RESEARCH QUESTIONS:

Is the Trauma-Focused Art Therapy protocol an effective treatment of patients' trauma-related complaints

How do patients and art therapists experience this method?

OBJECTIVES:

The aim of this research is to gain insight into the effectiveness and functioning of trauma-focused AT. This contributes to evidence about the effectiveness of trauma treatment.

The aim is to better align trauma treatment with patients' needs to work on personal recovery in a different way. The protocol is tested in practice with the help of patients and professionals on: symptom reduction and psychological health.

HYPOTHESIS:

Art therapy offers an appropriate treatment for the group of multiple and long-term traumatized patients, who avoid and/or have difficulty talking about traumatic memories, because the visual and tangible character of art therapy seems to match the often wordless, visual and sensory nature of traumatic memories.Trauma-focused art therapy reduces PTSD symptoms (avoidance, arousal and re-experiencing) and depression (if there is comorbidity) and enhances self-confidence/self-esteem, mental resilience and positive health.

Study Type

Interventional

Enrollment (Estimated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Gelderland
      • Nijmegen, Gelderland, Netherlands
        • Recruiting
        • HAN University of Applied Sciences
        • Contact:
        • Principal Investigator:
          • Suzanne Haeyen
        • Sub-Investigator:
          • Jackie Heijman
        • Sub-Investigator:
          • Hans Wouters
        • Sub-Investigator:
          • Karin Alice Schouten

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having trauma-related symptoms ((i.e. nightmares, flashbacks, persistent fatigue or depression, anxiety in regards to specific triggers, sleep disorders)
  • Being eligible for art therapy on discretion of multidisciplinary treatment panel (consisting of, for example. a psychiatrist, psychologists, sociotherapists, and art therapists)
  • Being motivated to work on traumatic memories

Exclusion Criteria:

  • Psychosis or acute crisis
  • intellectual disability (precluding the filling out of questionnaires).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control Period - Intervention Period
Multiple baseline single case experimental design wherein all patients are first assigned to the control condition (or control period) are then assigned to the intervention condition (or intervention period) and finally to the follow-up period (control period). Patients are randomized for the time (t) at which they start with the intervention.

Individual Trauma Focused Art Therapy (TFAT) consisting of 10 sessions. Each session lasts 60 minutes. Sessions are aimed at trauma recovery using visual art therapy. The sessions cover an introduction, making pieces of artwork, and reflection. Three phases can be distinguished:

Phase 1: 'stabilization and symptom reduction', i.e. exploring traumatic and positive memories, imagining a lifecourse, and expressing a safe haven (4 sessions).

Phase 2:'uttering and expressing memories', i.e. expressing chosen memories by making 5 pieces of artwork. Materials that can be used include clay, paint, graphite pencil or crayons and if needed with support of imagination using relevant photographs or objects (5 sessions).

Phase 3: 'integration and meaning attribution', i.e. ordering and assembling of the 5 pieces of artwork. Patients are asked to appraise the memories in the here-and-now present (c.f. mindfulness-based cognitive therapy) (1 session).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-expression and Emotion Regulation in Art Therapy Scale
Time Frame: 15-18 repeated measures of emotional self-expression and regulation, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Self-expression and Emotion Regulation in Art Therapy Scale (SERATS): Assessment of emotional self-expression and regulation during therapy with 9 5-point scale items
15-18 repeated measures of emotional self-expression and regulation, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rosenberg Self-Esteem Scale
Time Frame: 15-18 repeated measures of self-esteem, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Rosenberg Self-Esteem Scale (RSES): Self-esteem assessed with ten 4-point scale items
15-18 repeated measures of self-esteem, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Resilience Scale
Time Frame: 15-18 repeated measures of mental resiliency, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Resilience Scale (RS): Mental resiliency i.e. how patients cope with challenges, drawbacks, and distressing circumstances assessed with 25 4-point scale items
15-18 repeated measures of mental resiliency, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Beck Depression Inventory
Time Frame: 15-18 repeated measures of depression severity, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Beck Depression Inventory (BDI): Severity of depression scored in the domains of affective, cognitive and somatic symptoms assessed with 21 4-point scale items
15-18 repeated measures of depression severity, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Mental Health Continuum Short Form (MHC-SF)
Time Frame: 15-18 repeated measures of positive mental health, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Mental Health Continuum Short Form (MHC-SF): positive mental health in the domains of emotional, psychological, and social wellbeing using 14 items
15-18 repeated measures of positive mental health, i.e. weekly over the course of 18 weeks (2-5 weeks control period + 10 weeks intervention + 3 weeks follow-up))
Post-traumatic stress disorder Check List
Time Frame: Change from baseline PTSD symptoms at 15 weeks (after completion of intervention)
Post-traumatic stress disorder Check List (PCL): screener of symptoms of PTSD using 20 items based on the Diagnostic and Statistical Manual 5th edition (DSM-5)
Change from baseline PTSD symptoms at 15 weeks (after completion of intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Christine De Vries, Msc., HAN University of Applied Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2022

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

August 31, 2024

Study Registration Dates

First Submitted

October 12, 2022

First Submitted That Met QC Criteria

October 20, 2022

First Posted (Actual)

October 25, 2022

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 13, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TFAT SU1424 -101

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We will not make IPD directly available, but rather indirectly through a description of the meta-data and contact information of the principal investigator, to whom data requests can be sent.

IPD Sharing Time Frame

After publication of the main paper until 10 years after this publication.

IPD Sharing Access Criteria

The principal investigator will investigate whether requests are reasonable and feasible and adhere to ethical considerations.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

Clinical Trials on Trauma-Focused Art Therapy (TFAT)

3
Subscribe